Table 2. Quality assessment of eligible studies Newcastle-Ottawa Scale (NOS) score.
| Author | Country | Selection | Comparability | Outcome | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adequate of case definition | Representativeness of the cases | Selection of Controls | Definition of Controls | Comparability of cases and controls | Ascertainment of exposure | Same method of ascertainment | Non-Response rate | |||
| Xiao XH 2020 | China | * | * | * | * | * | * | * | * | 8 |
| He XZ 2016 | China | * | * | * | * | ** | * | * | * | 9 |
| Tong LF 2019 | China | * | * | * | * | * | - | * | - | 6 |
| Chen L 2020 | China | * | * | * | * | * | * | * | * | 8 |
| Zhao WG 2020 | China | * | * | * | * | * | * | * | * | 8 |
| Bing ZX 2021 | China | * | * | * | * | * | * | * | * | 8 |
| Zhang XD 2020 | China | * | * | * | * | * | * | * | * | 8 |
| Fu Y 2019 | China | * | * | * | * | * | * | * | * | 8 |
| Yan RC 2019 | China | * | * | * | * | * | * | * | * | 8 |
| Li M 2019 | China | * | * | * | * | ** | * | * | * | 9 |
| Bai Y 2019 | China | * | * | * | * | * | * | - | - | 6 |
| Qu CX 2019 | China | * | * | * | * | * | * | - | - | 6 |